Streptococcal A vaccine
Latest Information Update: 10 Jul 2002
At a glance
- Originator Nonindustrial source; University of Tennessee
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Streptococcal infections
Most Recent Events
- 08 Jun 2000 Preclinical development for Streptococcal infections in Australia (Unknown route)
- 08 Jun 2000 A preclinical study has been added to the Bacterial Infections immunogenicity section
- 19 May 1995 An animal study on the immunogenicity of streptococcal M protein fragment fused to E. coli has been added to the Bacterial Infections immunogenicity section